Cathay Biotech Inc Cash Flow Reinvestment Rate
Cathay Biotech Inc cash flow reinvestment rate. Cathay Biotech Inc (688065) has a Cash Flow Reinvestment Rate of 0.31x as of June 2025, reinvesting CN¥78.51 Million (capex CN¥78.51 Million ) from operating cash flow of CN¥251.82 Million. Explore 688065 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Cathay Biotech Inc (2017–2025)
Cash flow reinvestment rate of Cathay Biotech Inc from 2017 to 2025. Historical reinvestment intensity for Cathay Biotech Inc across 8 annual periods. Explore Cathay Biotech Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Cathay Biotech Inc Cash Flow Reinvestment Rate by Year (2017–2025)
Cathay Biotech Inc cash flow reinvestment rate by year from 2017 to 2025. Year-by-year capital reinvestment analysis for Cathay Biotech Inc. For the full cash flow conversion analysis, see 688065 cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.87x | CN¥755.33 Million | CN¥404.12 Million | CN¥743.46 Million | ▼ -7.9% |
| 2024 | 2.03x | CN¥1.67 Billion | CN¥820.93 Million | CN¥843.31 Million | ▼ -63.1% |
| 2023 | 5.49x | CN¥3.13 Billion | CN¥569.45 Million | CN¥1.57 Billion | ▼ -47.4% |
| 2022 | 10.45x | CN¥8.40 Billion | CN¥803.67 Million | CN¥4.20 Billion | ▲ +287.8% |
| 2021 | 2.69x | CN¥1.60 Billion | CN¥594.18 Million | CN¥1.47 Billion | ▼ -29.2% |
| 2020 | 3.81x | CN¥1.96 Billion | CN¥514.96 Million | CN¥763.11 Million | ▼ -20.3% |
| 2019 | 4.78x | CN¥1.72 Billion | CN¥359.62 Million | CN¥511.14 Million | ▼ -74.3% |
| 2017 | 18.62x | CN¥995.09 Million | CN¥53.45 Million | CN¥995.09 Million | — |